首页> 外文期刊>RAIRO Operation Research >MILP-HYPERBOX CLASSIFICATION FOR STRUCTURE-BASED DRUG DESIGN IN THE DISCOVERY OF SMALL MOLECULE INHIBITORS OF SIRTUIN6
【24h】

MILP-HYPERBOX CLASSIFICATION FOR STRUCTURE-BASED DRUG DESIGN IN THE DISCOVERY OF SMALL MOLECULE INHIBITORS OF SIRTUIN6

机译:SIRTUIN6的小分子抑制剂发现中基于结构的药物设计的MILP-Hyperbox分类

获取原文
获取原文并翻译 | 示例
       

摘要

Virtual screening of chemical libraries following experimental assays of drug candidates is a common procedure in structure-based drug discovery. However, virtual screening of chemical libraries with millions of compounds requires a lot of time for computing and data analysis. A priori classification of compounds in the libraries as low-and high-binding free energy sets decreases the number of compounds for virtual screening experiments. This classification also reduces the required computational time and resources. Data analysis is demanding since a compound can be described by more than one thousand attributes that make any data analysis very challenging. In this paper, we use the hyperbox classification method in combination with partial least squares regression to determine the most relevant molecular descriptors of the drug molecules for an efficient classification. The effectiveness of the approach is illustrated on a target protein, SIRT6. The results indicate that the proposed approach outperforms other approaches reported in the literature with 83.55% accuracy using six common molecular descriptors (SC-5, SP-6, SHBd, minHaaCH, maxwHBa, FMF). Additionally, the top 10 hit compounds are determined and reported as the candidate inhibitors of SIRT6 for which no inhibitors have so far been reported in the literature.
机译:在对候选药物进行实验检测后,对化学文库进行虚拟筛选是基于结构的药物发现中的常见程序。但是,对具有数百万种化合物的化学库进行虚拟筛选需要大量时间进行计算和数据分析。库中化合物的先验分类为低结合和高结合自由能集,可减少用于虚拟筛选实验的化合物的数量。这种分类还减少了所需的计算时间和资源。数据分析的要求很高,因为化合物可以由一千多个属性来描述,这使得任何数据分析都非常具有挑战性。在本文中,我们使用超盒子分类方法结合偏最小二乘回归来确定药物分子的最相关分子描述符,以进行有效分类。在靶蛋白SIRT6上说明了该方法的有效性。结果表明,使用六种常见分子描述符(SC-5,SP-6,SHBd,minHaaCH,maxwHBa,FMF),所提出的方法以83.55%的精度优于文献中报道的其他方法。此外,确定了排名前10位的命中化合物,并将其报告为SIRT6的候选抑制剂,迄今为止,尚未在文献中报道任何抑制剂。

著录项

  • 来源
    《RAIRO Operation Research》 |2016年第2期|387-400|共14页
  • 作者单位

    Koc Univ, Dept Computat Sci & Engn, TR-34450 Istanbul, Turkey;

    Koc Univ, Dept Ind Engn, TR-34450 Istanbul, Turkey;

    Koc Univ, Dept Mol Biol & Genet, TR-34450 Istanbul, Turkey|Koc Univ, Dept Chem & Biol Engn, TR-34450 Istanbul, Turkey;

    Koc Univ, Dept Ind Engn, TR-34450 Istanbul, Turkey;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Structure-based drug design; SIRT6; MILP-HB;

    机译:基于结构的药物设计;SIRT6;MILP-HB;
  • 入库时间 2022-08-18 03:05:49

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号